Porcine Vaccines Market

Porcine Vaccines Market Size, Share & Trends Analysis Report

Porcine Vaccines Market Size, Share & Trends Analysis Report By Disease Indication ( Diarrhoea, Swine Influenza, Porcine Reproductive And Respiratory Virus (PRRSV), Pporcine Circovirus Associated Disease (PCVAD) And Others), By Technology Type ( Inactivated Vaccine, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines), Based On Region, And Segment Forecasts, 2022 - 2028

Published
Report ID : BMRC 147
Number of pages : 300
Published Date : May 2023
Category : Biotechnology
Delivery Timeline : 48 hrs

Porcine Vaccine Market 2022-2028 The forecast period 2022-2028 is expected to show noticeable growth in Porcine Vaccine Market. There will be a new resurgence in the sales and utilisation of Porcine Vaccine. Are you ready to cope up with growing market?  No, then have a look at our report overview and send your query to us.

Scope

Increase in disease indication among swine, technological advancement of RNA strand methodology, and cultivation of pig for growth in standard of living is accounted to form growth in porcine vaccine segment. Increase trading facilities of live hogs/pigs, demand of pork meat and innovation through clinical research activities are some of the drivers expected to drive the market.

Our report studies global Porcine Vaccine Market and covers historical and forecast data for application, regional and country.

Porcine Vaccine Market top players

  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Ceva Santé Animale
  • Elanco (Eli Lilly and Company)
  • Merck & Co. Inc.
  • Merial (Sanofi)
  • Vetoquinol
  • Zoeti Inc.
  • Formosa Biomedical INC
  • MVP
  • FATRO SpA
  • HIPRA
  • MSD Animal Health
  • Novartis AG

Along with these leading players, there are number of other small and mid-sized players who are coming with huge investment and innovative product launch in the Porcine Vaccine industry.

Market Segmentation

By Disease Indication,

  • Diarrhoea
  • Swine influenza
  • Porcine reproductive and respiratory virus (PRRSV)
  • Pporcine circovirus associated disease (PCVAD)
  • Others

Based upon Disease Indication segment, Diarrhoea product type segment has significant market share in historic year and it is expected to maintain its dominance in forecast period.

By Technology Type,

  • Inactivated vaccine
  • Live attenuated vaccines
  • Toxoid vaccines
  • Recombinant vaccines
  • Conjugate vaccines
  • DNA vaccines

Based upon Technology segment, inactivated segment has significant market share in historic year and it is expected to maintain its dominance in forecast period.

By End User Type,

  • Veterinary Hospitals
  • Hog/Pig Production Farms

Based upon End User segment, Veterinary Hospitals segment has significant market share in historic year and it is expected to maintain its dominance in forecast period.

By Region

  • North America

    • U.S.
    • Canada
  • Europe

    • U.K.
    • France
    • Germany
    • Italy
  • Asia Pacific

    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America

    • Brazil
    • Mexico
  • Middle East and Africa

    • GCC
    • Africa
    • Rest of Middle East and Africa

Our new report discusses issues and events affecting the Porcine Vaccine Market.

The report covers discussions and qualitative analyses:

Technological Development

Demand Of Pork Meat and Innovation Through Clinical Research Activities

SUMMARY